Redwood Investments, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Redwood Investments, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$12,580,000
+4.1%
108,999
-12.2%
1.07%
+5.1%
Q3 2020$12,081,000
-24.5%
124,094
-4.9%
1.02%
-28.1%
Q2 2020$16,008,000
+41.9%
130,444
+1.3%
1.42%
+6.3%
Q1 2020$11,280,000
-12.7%
128,813
+4.2%
1.33%
+9.8%
Q4 2019$12,921,000
-13.1%
123,577
-4.4%
1.21%
+5.9%
Q3 2019$14,866,000
-13.1%
129,232
+30.3%
1.14%
-9.2%
Q2 2019$17,100,000
-20.3%
99,192
-22.0%
1.26%
-19.5%
Q1 2019$21,448,000
+104.7%
127,235
+18.3%
1.57%
+59.1%
Q4 2018$10,476,000
+59.2%
107,569
+115.8%
0.98%
+111.6%
Q4 2017$6,581,00049,8530.46%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders